06:10 EDT BridgeBio (BBIO) files automatic mixed securities shelf
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBIO:
- BridgeBio Pharma Announces $500 Million Stock Repurchase Program
- BridgeBio reports Q1 EPS (84c), consensus (62c)
- BridgeBio receives regulatory approval in Brazil for Beyonttra
- BridgeBio price target raised to $102 from $95 at Truist
- Zemansky Reiterates Buy on BridgeBio, Nudges Price Target to $96 on Attruby Edge and Reduced Tafamidis Patent Overhang